MAAT INDEX

CLAIM #18541 · CVS Health Corp (CVS) · 2025Q1 earnings call · May 1, 2025 · due Dec 31, 2025

Michael, maybe just one thing to add as we look in the back half of the year, obviously PCW is running as well as we would expect, with the caution to watch out, is the vaccines and immunizations as we anticipate volume impacts, depending on the government actions for end of this year.

Tom Cowhey · CFO

PENDING
graded after results covering Dec 31, 2025 are reported

In context

rom November of ’23, when we first announced this, the goal of this is to address, one, the cross-subsidization that exists in the marketplace across brands and generics, and to create stable, more predictable margins and pass the value back to payors in a much more predictable way when we receive that. Where we are today, we’ve moved 100% of commercial scripts, as we said, on 1/1/25 into CostVantage. We’ve moved the cash discount space into CostVantage as well. We’re working very hard for 1/1/26 to move the rest of our scripts into this model and we’ll provide more updates on the outcomes of this, but we’re really pleased with where we are with this and we’re really pleased with the results of PCW and the strong performance powered by the 200,000 colleagues we have in retail. Tom Cowhey: Michael, maybe just one thing to add as we look in the back half of the year, obviously PCW is running as well as we would expect, with the caution to watch out, is the vaccines and immunizations as we anticipate volume impacts, depending on the government actions for end of this year. Operator: We now have Charles Rhyee with TD Cowen. Please go ahead. Charles Rhyee: Yes, thanks for taking the question. David, wanted to circle back to your comments earlier about the law passed in Arkansas. Obviously I think it’s been reported that you could end up potentially closing your retail locations in the state. Obviously some other states are considering similar legislation, and certainly maybe Arkansas is an easy state to exit from if you had to; but if we think this gets adopted more broadly--and I think back to the Blue Shield of California contract, where they kind of split that contract up and you guys ended up retaining the specialty pharmacy part of the business, and I think at the time you guys had said that was the most profitable part of the business. If that’s the cas

Verify independently

SEC filings for CVS · Claim quote is verbatim from the 2025Q1 earnings call.